TH Stock

After what he calls a “soft” first quarter, Leede Jones Gable analyst Doug Loe has maint... Read More

Following the company’s third quarter results, Leede Jones Gable analyst Douglas Loe remains b... Read More

Softer than expected quarterly revenue and more muted guidance from management are reasons to pare b... Read More

The share price for drug company Theratechnologies (Theratechnologies Stock Quote, Charts, News, Ana... Read More

The stock has fallen on hard times over the past couple of years, but investors should be seeing bet... Read More

Research Capital analyst André Uddin delivered an update to clients on Friday on HIV-specializing T... Read More

It’s been steady as it goes for Montreal-based endocrinology and oncology drug developer Theratech... Read More

New quarterly results from Canadian drug developer Theratechnologies (Theratechnologies Stock Quote,... Read More

André Uddin from Research Capital Corporation thinks Theratechnologies (Theratechnologies Stock Quo... Read More

André Uddin from Research Capital Corporation is slightly more tentative on Canadian biotech name ... Read More

It seems fair to say that biotech hasn’t been the hottest of fields for much of this year. Money c... Read More

André Uddin from Research Capital Corporation is still tight with Theratechnologies (Theratechnolog... Read More

With its second quarter now in the books, André Uddin from Research Capital Corporation has maintai... Read More

Calling the company’s pipeline underappreciated, Mackie Research analyst André Uddin raised his t... Read More

Specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH) misse... Read More

On the basis of extended timelines for clinical testing, Echelon Wealth Partners analyst Douglas Loe... Read More

Mackie Research analyst André Uddin is staying bullish on specialty pharma company Theratechnologie... Read More

There’s good value to be had in 2020 from biotech stocks, says Eden Rahim of Next Edge Capital, wh... Read More